NDC Active Ingredient Daratumumab

List of the 3 NDC products with the active ingredient Daratumumab. This medication is used to treat a certain type of cancer (multiple myeloma). Daratumumab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
57894-502Darzalex DaratumumabInjection, Solution, ConcentrateIntravenousJanssen Biotech, Inc.Human Prescription Drug
57894-503Darzalex Faspro Daratumumab And Hyaluronidase-fihj (human Recombinant)InjectionSubcutaneousJanssen Biotech, Inc.Human Prescription Drug
57894-505Darzalex Iv DaratumumabInjection, Solution, ConcentrateIntravenousJanssen Biotech, Inc.Human Prescription Drug